BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1012 related articles for article (PubMed ID: 17971532)

  • 21. Isolation of a natural inhibitor of human malignant glial cell invasion: inter alpha-trypsin inhibitor heavy chain 2.
    Werbowetski-Ogilvie TE; Agar NY; Waldkircher de Oliveira RM; Faury D; Antel JP; Jabado N; Del Maestro RF
    Cancer Res; 2006 Feb; 66(3):1464-72. PubMed ID: 16452202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A.
    Sliwa M; Markovic D; Gabrusiewicz K; Synowitz M; Glass R; Zawadzka M; Wesolowska A; Kettenmann H; Kaminska B
    Brain; 2007 Feb; 130(Pt 2):476-89. PubMed ID: 17107968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain tumor invasion model system using organotypic brain-slice culture as an alternative to in vivo model.
    Jung S; Kim HW; Lee JH; Kang SS; Rhu HH; Jeong YI; Yang SY; Chung HY; Bae CS; Choi C; Shin BA; Kim KK; Ahn KY
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):469-76. PubMed ID: 12242510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
    Tsunoda K; Kitange G; Anda T; Shabani HK; Kaminogo M; Shibata S; Nagata I
    Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aquaporin-4 in glioma invasion and an analysis of molecular mechanisms.
    Ding T; Gu F; Fu L; Ma YJ
    J Clin Neurosci; 2010 Nov; 17(11):1359-61. PubMed ID: 20685122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes.
    Junge CE; Lee CJ; Hubbard KB; Zhang Z; Olson JJ; Hepler JR; Brat DJ; Traynelis SF
    Exp Neurol; 2004 Jul; 188(1):94-103. PubMed ID: 15191806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IQGAP1 protein specifies amplifying cancer cells in glioblastoma multiforme.
    Balenci L; Clarke ID; Dirks PB; Assard N; Ducray F; Jouvet A; Belin MF; Honnorat J; Baudier J
    Cancer Res; 2006 Sep; 66(18):9074-82. PubMed ID: 16982749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ECM-mediated glioma cell invasion.
    Goldbrunner RH; Bernstein JJ; Tonn JC
    Microsc Res Tech; 1998 Nov; 43(3):250-7. PubMed ID: 9840803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost of migration: invasion of malignant gliomas and implications for treatment.
    Giese A; Bjerkvig R; Berens ME; Westphal M
    J Clin Oncol; 2003 Apr; 21(8):1624-36. PubMed ID: 12697889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NG2/HMP proteoglycan as a cancer therapeutic target.
    Chekenya M; Immervoll H
    Methods Mol Biol; 2007; 361():93-117. PubMed ID: 17172708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nestin expression in astrocytic tumors delineates tumor infiltration.
    Kitai R; Horita R; Sato K; Yoshida K; Arishima H; Higashino Y; Hashimoto N; Takeuchi H; Kubota T; Kikuta K
    Brain Tumor Pathol; 2010 Apr; 27(1):17-21. PubMed ID: 20425043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated levels of mortalin expression in human brain tumors.
    Takano S; Wadhwa R; Yoshii Y; Nose T; Kaul SC; Mitsui Y
    Exp Cell Res; 1997 Nov; 237(1):38-45. PubMed ID: 9417864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of taurolidine on brain tumor cells.
    Stendel R; Stoltenburg-Didinger G; Al Keikh CL; Wattrodt M; Brock M
    Anticancer Res; 2002; 22(2A):809-14. PubMed ID: 12014655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.
    Bruna A; Darken RS; Rojo F; Ocaña A; Peñuelas S; Arias A; Paris R; Tortosa A; Mora J; Baselga J; Seoane J
    Cancer Cell; 2007 Feb; 11(2):147-60. PubMed ID: 17292826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subclinical photodynamic therapy treatment modifies the brain microenvironment and promotes glioma growth.
    deCarvalho AC; Zhang X; Roberts C; Jiang F; Kalkanis SN; Hong X; Lu M; Chopp M
    Glia; 2007 Aug; 55(10):1053-60. PubMed ID: 17551928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autocrine semaphorin 3A signaling promotes glioblastoma dispersal.
    Bagci T; Wu JK; Pfannl R; Ilag LL; Jay DG
    Oncogene; 2009 Oct; 28(40):3537-50. PubMed ID: 19684614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells.
    Chen DL; Ping YF; Yu SC; Chen JH; Yao XH; Jiang XF; Zhang HR; Wang QL; Bian XW
    Biochem Biophys Res Commun; 2009 Apr; 381(3):448-52. PubMed ID: 19233142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of growth factors in the malignant and invasive progression of intrinsic brain tumours.
    Finn PE; Bjerkvig R; Pilkington GJ
    Anticancer Res; 1997; 17(6B):4163-72. PubMed ID: 9428350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of SEMA3G on migration and invasion of glioma cells.
    Zhou X; Ma L; Li J; Gu J; Shi Q; Yu R
    Oncol Rep; 2012 Jul; 28(1):269-75. PubMed ID: 22562223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of extracellular matrix components in a highly infiltrative in vivo glioma model.
    Mahesparan R; Read TA; Lund-Johansen M; Skaftnesmo KO; Bjerkvig R; Engebraaten O
    Acta Neuropathol; 2003 Jan; 105(1):49-57. PubMed ID: 12471461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.